Zimmer Biomet Announces Third Quarter 2026 Financial Results
Key Highlights
- ➤Q3 net sales $2.063 billion, up 3.1% reported and 3.7% constant currency
- ➤Full-year 2026 organic constant-currency revenue growth guidance raised to 3.0% - 3.5%
- ➤Adjusted diluted EPS guidance raised to $8.50- $8.60
- ➤Q3 adjusted diluted EPS $1.90, consistent with the prior year period
- ➤Q3 diluted EPS $1.00, down 13.8% year over year
Expert Statements
Ivan Tornos, Chairman, President and CEO of Zimmer Biomet
“We are very pleased with our solid third quarter results, growing net sales 3.7% on a constant-currency basis and generating strong operating and free cash flow. Our Hips, S.E.T. and Technology & Data, Bone Cement and Surgical franchises – representing two-thirds of our book of business – grew at upper single digit or double-digit rates, validating the progress of our diversification strategy, the strength of our innovation engine and the significant strides we are making in commercial execution. This broad-based performance gives us confidence to raise our full-year organic constant-currency sales growth and adjusted EPS guidance. I'm very proud of our team and believe we will continue to build on this momentum as we advance our Mission and ultimately position the Company for sustained long-term growth.”
Zimmer Biomet Announces Third Quarter 2026 Financial Results PR Newswire
* Third quarter net sales of $2.063 billion increased 3.1% on a reported basis and 3.7% on a constant currency(1) basis * Third quarter diluted earnings per share were $1.00, a decrease of 13.8%; adjusted(1) diluted earnings per share were $1.90, consistent with the prior year period * Company updates full-year 2026 financial guidance WARSAW, Ind., Nov. 4, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended September 30, 2026. The Company reported third quarter net sales of $2.063 billion, an increase of 3.1% over the prior year period and an increase of 3.7% on a constant currency(1) basis. Net earnings for the third quarter were $191.6 million, or $362.8 million on an adjusted(1) basis.
Get started
Create a free account to read the full story.